Emavusertib, CAS [[1801344-14-8]]

Produktübersicht

• Artikelname: Emavusertib, CAS [[1801344-14-8]]
• Artikelnummer: MCE-HY-135317
• Hersteller Artikelnummer: HY-135317
• Alternativnummer: MCE-HY-135317-5MG,MCE-HY-135317-25MG,MCE-HY-135317-50MG,MCE-HY-135317-100MG,MCE-HY-135317-10MG,MCE-HY-135317-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: CA-4948

Produktbeschreibung

Emavusertib is an orally active inhibitor for IRAK4 (IC50=57 nM) and FLT3. Emavusertib inhibits NF-kappaB and MyD88 signaling pathways, reduces the generation of pro-inflammatory cytokines like IL-6 and IL-10, thereby exhibiting anti-inflammatory and anti-proliferative activities against cancer cells, leading to cell apoptosis. Emavusertib exhibits antitumor activity in mouse model

Produkteigenschaften

• Molekulargewicht: 491.50
• Reinheit: 99.97
• CAS Nummer: [1801344-14-8]
• Formel: C24H25N7O5
• Target-Kategorie: Apoptosis,FLT3,IRAK,MyD88,NF-kappaB

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound